用人类诱导的多能干干细胞建模上膜大动脉狭窄综合征
Xin Ge1, Yongming Ren, Oscar Bartulos
1YCVRC Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, Yale Stem Cell Center, Ste 773A, 300 George St, New Haven, CT 06510, USA.
Circulation
|August 24, 2012
概括
超膜大动脉狭窄症 (SVAS) 患者的细胞显示异常的光滑肌细胞增殖和迁移. 这些患者特异性诱导多能干细胞衍生平滑肌细胞 (iPSC-SMCs) 为研究SVAS和开发疗法提供了一个模型.
科学领域:
- 心血管生物学 心血管生物学
- 干细胞生物学 干细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 上大动脉狭窄 (SVAS) 是由弹性素 (ELN) 基因突变引起的,导致血管光滑肌细胞 (SMC) 过度生长和动脉狭窄.
- 针对患者的SMC对于了解SVAS病原和开发治疗方法至关重要.
研究的目的:
- 来自SVAS患者的人类诱导多能干细胞 (iPSC) 线的开发和表征.
- 通过使用患者衍生的iPSC-SMC来研究SVAS背后的细胞和分子机制.
主要方法:
- 从患有ELN基因突变的SVAS患者生成的iPSC线.
- 将iPSC分化为SMC (iPSC-SMC),并将SVAS iPSC-SMC与对照进行比较.
- 评估了SMC的分化,扩散,迁移和信号通路 (RhoA,ERK1/2).
主要成果:
- 与对照组相比,SVAS iPSC-SMC 显示的有组织的光滑肌肉α-actin 丝束较少.
- SVAS iPSC-SMC显示出明显更高的扩散和迁移率.
- 弹性蛋白或RhoA信号增强部分挽救了丝的形成;ERK1/2活性升高与过度增殖有关.
结论:
- SVAS iPSC-SMCs准确地模拟了疾病的关键病理特征.
- 这个iPSC-SMC模型为研究SVAS机制和治疗开发提供了一个有价值的平台.
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...


